Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
G protein-coupled receptor 26
(
GPR26
) is one of the G-protein-coupled receptors (GPCRs), which comprise the largest family of membrane proteins and mediate most of the physiological responses to hormones, neurotransmitters and environmental stimulants. Although GPCRs are considered to play an important role in the pathophysiology of neurodegenerative disorders, it is uncertain whether
GPR26
is involved in the pathogenesis of polyglutamine and intranuclear inclusion body diseases. We immunohistochemically examined the brain tissues of patients with four polyglutamine diseases (Huntington's disease, dentatorubral-pallidoluysian atrophy, and spinocerebellar
ataxia
types 1 and 3) and intranuclear inclusion body disease, and normal control subjects. In controls, anti-
GPR26
antibody immunolabeled the neuronal cytoplasm in a diffuse granular pattern. Neuronal nuclear inclusions in polyglutamine diseases were immunopositive for
GPR26
. In intranuclear inclusion body disease,
GPR26
-positive nuclear inclusions were found in both neurons and glial cells. Marinesco bodies in aged control subjects were also positive for
GPR26
. Double immunofluorescence analysis revealed co-localization of
GPR26
with polyglutamine or ubiquitin in these nuclear inclusions. These findings suggest that
GPR26
may have a common role in the formation or degradation of intranuclear inclusions in several neurodegenerative diseases.
...
PMID:G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases. 2630 44